Industry / France
GlaxoSmithKline's Cervarix Added To Reimbursement List
July 2008 | Industry NewsGlaxoSmithKline's cervical cancer vaccine Cervarix has been approved for reimbursement by France's state-funded health insurance system, reversing an earlier decision by the French National Authority for Health.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
